Axon Capital’s Morgan Stanley MS Stock Holding History

Axon Capital’s Portfolio MS Stock Details MS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-47,400	Closed	-$2.03M	–	14
2017 Q1	$2.03M	Buy	+47,400	New	+$2.1M	2.03%	11

Other funds holding MS

Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Axon Capital's MS Position: Q2 2017 in Review

Axon Capital sold out of Morgan Stanley (MS) in Q2 2017, closing a stake of 47,400 shares — an estimated $2.03M sold.

Axon Capital first reported a position in MS in Q1 2017 and held it in 1 quarter. The position peaked at $2.03M in Q1 2017. 919 funds tracked by Wall St. Rank hold MS as of Q2 2017.

Axon Capital reported no remaining Morgan Stanley position as of Q2 2017 after selling out during the quarter.
Axon Capital sold 47,400 Morgan Stanley shares in Q2 2017, an estimated $2.03M.
Axon Capital first reported a position in Morgan Stanley in Q1 2017 and held it in 1 quarter.
Axon Capital's Morgan Stanley position peaked at $2.03M in Q1 2017.
919 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2017.

Based on Axon Capital's 13F filing for Q2 2017, filed 14 Aug 2017.